A Phase 1, Double-blind, Randomized, Placebo-controlled, Ascending Multiple Oral Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MYK-461 in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Mavacamten (Primary)
- Indications Hypertrophic cardiomyopathy
- Focus Adverse reactions
- Sponsors MyoKardia
- 21 Mar 2017 Status changed from active, no longer recruiting to completed.
- 26 Aug 2016 Status changed from recruiting to active, no longer recruiting.
- 11 Jul 2016 Results published in a MyoKardia media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History